Fundz
New|Fundz now works inside Claude2 min

AI made execution free. Knowing first is the whole game now.

The advantage goes to whoever is first into the right conversations, most often. Fundz stacks those odds: more of the moments that create demand than anyone else catches, as they happen, matched to who you sell to, with the decision maker to call. Now it answers in Claude too: ask for today’s leads and who to reach, then write the note in the same window. Not a feed. Not a list you rent. A system for being first.

Trusted by

OracleSnowflakeCloudflareLinkedInGoogleSalesforce
4.8/5 on G2· Since 2015

DataMEDS to acquire Helomics AI Cancer Lab

PUBLIC · MEDSSep 21, 2026about 4 hours ago

Acquiring Company

DataMeds AI

Acquired Company

Helomics Corporation

TampaPittsburghInformation TechnologyHealth CareArtificial IntelligenceMachine LearningBiotechnologyHealth CareArtificial Intelligence

Description

DataMEDS AI, Inc. has recently acquired Helomics Corporation's AI-driven Cancer Diagnostics Lab from Axe Compute. This strategic acquisition aligns with DataMEDS' focus on enhancing its health data services and expanding its market reach. The deal is part of a broader initiative to innovate in the health technology sector. The company also announced the settlement of related litigation, improving its financial standing.

Company Information

Company

DataMeds AI

Location

Tampa, Florida, United States

About

DataMeds AI, Inc. is a Health IT company focusing on integrating technology, pharmacy, and telemedicine services to improve healthcare experiences. The company utilizes its artificial intelligence platform EinsteinRx™ and blockchain technologies. It aims to facilitate the compliant monetization of health data. DataMeds AI is also known for its subsidiary, Corexa Health, which provides various pharmacy services.

Fundz sees it the moment DataMeds AI makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Nikul
Senior decision-maker at this company
••••••••@••••••••

See Nikul's verified email →

Shafaat
Senior decision-maker at this company
••••••••@••••••••

See Shafaat's verified email →

Predictive Intelligence
Strategic

ML-powered predictions for DataMeds AI's next move

Learn about Strategic plan

M&A Insights

Based on deal data
Integration timeline
70% of M&A integrations take 12-24 months to complete
Tech stack consolidation
83% of merged companies consolidate technology vendors within first year
Post-acquisition investment
Companies increase IT spending by 23% on average after acquisitions
Success factor
M&A deals with strong technology integration plans are 2.5x more likely to succeed

Frequently asked

Who acquired Helomics Corporation?

Helomics Corporation was acquired by DataMeds AI, based in Tampa. The deal was reported on September 21, 2026. DataMeds AI, Inc. is a Health IT company focusing on integrating technology, pharmacy, and telemedicine services to improve healthcare experiences. DataMeds AI is publicly traded (MEDS) and operates in Information Technology.

When did DataMeds AI acquire Helomics Corporation?

DataMeds AI's acquisition of Helomics Corporation was reported on September 21, 2026. DataMEDS AI, Inc. has recently acquired Helomics Corporation's AI-driven Cancer Diagnostics Lab from Axe Compute. This strategic acquisition aligns with DataMEDS' focus on enhancing its health data services and expanding its market reach. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.

What does Helomics Corporation do?

Helomics is a functional precision medicine oncology platform that utilizes artificial intelligence to analyze tumor data for drug discovery and treatment decisions. It is known for its innovative approaches in cancer diagnostics. It is privately held, operating in Biotechnology, and is based in Pittsburgh.

This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.

145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 285,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.